skip to main content

Bordetella bronchiseptica

Bordetella bronchiseptica

Catalogue No.

NCTC 8344

Current Name

Bordetella bronchiseptica

Type Strain

Reference Strain

Culture Conditions

Growth Conditions on Solid Media

Nutrient agar, 37°C, O₂

Biological and Genomic Info

Susceptibility

Potassium cyanide: +

Gram Stain Result

Negative

Enzyme Tests

Arginine deiminase: -

Catalase: +

Gelatinase: -

Strain Data

(ATCC 4617, PCI 1701, WHO 11, NCIB 9935) / ATCC in 1951 / Assay of Polymyxin B, colistin, sulphomethate, sulphomyxin and Dimethylchlortetracycline / British Pharmacopoeia 1973, p. 104

Colony Appearance

Smooth, Shiny

Additional Info

Accession Date

01/01/1951

Depositor

ATCC

Previous Catalogue Name

Bordetella bronchiseptica

Applications

Bibliography

1973 BRITISH PHARMACOEPIA 104

Extended Bibliography

British pharmacopoeia 1973

Available Formats

  • Ampoule (Bacteria)

If use of this culture results in a scientific publication, it should be cited in the publication as: Bordetella bronchiseptica (NCTC 8344)

It is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.

The Culture Collections represent deposits of cultures from world-wide sources. While every effort is made to ensure details distributed by Culture Collections are accurate, Culture Collections cannot be held responsible for any inaccuracies in the data supplied. References where quoted are mainly attributed to the establishment of the cell culture and not for any specific property of the cell line, therefore further references should be obtained regarding cell culture characteristics. Passage numbers where given act only as a guide and Culture Collections does not guarantee the passage number stated will be the passage number received by the customer.

Cultures supplied by Culture Collections are for research purposes only. Enquiries regarding the commercial use of a cell line are referred to the depositor of the cell line. Some cell lines have additional special release conditions such as the requirement for a material transfer agreement to be completed by the potential recipient prior to the supply of the cell line. Please view the Terms & Conditions of Supply for more information.